Last deal

$42.3M
Local Amount - TWD 1.3B

Amount

Post-IPO Equity

Stage

27.06.2023

Date

2

all rounds

$42.3M

Total amount

General

About Company
Foresee Pharmaceuticals is a Taiwanese company developing drugs for cancer and chronic diseases.

Industry

Sector :

Subsector :

Keywords :

Company Type

For Profit

Last funding type

Post-IPO Equity

IPO status

Private

Description

Foresee Pharmaceuticals Co., Ltd. (FP) is a clinical-stage pharmaceutical company. Our mission is to serve patients. We strive to improve patients' quality of life and provide cure through innovative research. We are committed to apply the highest ethical standards to our products, services and communications. Foresee's core competency includes rapid development and commercialization of new drugs using its proprietary drug delivery technology as well as develop first-in-class NCE in disease areas of high unmet medical needs.